Home » Stocks » VSPR

Vesper Healthcare Acquisition Corp. (VSPR)

Stock Price: $11.02 USD -0.09 (-0.81%)
Updated Jan 25, 2021 4:00 PM EST - Market closed
Pre-market: $10.99 -0.03 (-0.27%) Jan 26, 5:20 AM
Market Cap 637.10M
Revenue (ttm) n/a
Net Income (ttm) -1,540
Shares Out 50.00M
EPS (ttm) 0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 25
Last Price $11.02
Previous Close $11.11
Change ($) -0.09
Change (%) -0.81%
Day's Open 11.05
Day's Range 10.97 - 11.20
Day's Volume 791,295
52-Week Range 10.05 - 12.00


Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GuruFocus - 2 weeks ago

The billionaire investor has been buying into the SPAC boom

Other stocks mentioned: PSTH, VSPRU, RBAC.UN, RTP.U
Seeking Alpha - 1 month ago

Vesper Healthcare Acquisition agrees to acquire HydraFacial in a deal valued at up to $1.1 billion. The experiential beauty health company is looking to build a platform of services for medica...

GlobeNewsWire - 1 month ago

WILMINGTON, Del., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Vesper Healthcare Acquisition Corp. (“Vesper”) (NASDAQ GS: VSPR) regarding possibl...

PRNewsWire - 1 month ago

NEW YORK, Dec. 14, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in Ne...

Yahoo Finance - 1 month ago

HydraFacial CEO on SPAC merger: Vesper Healthcare comes with capital and a great reputation

This segment originally aired on December 9, 2020. Beauty Health Company HydraFacial is merging with Vesper Healthcare in a $1.1B SPAC deal.

PRNewsWire - 1 month ago

NEW YORK, Dec. 10, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vesper Healthcare Acquisition...

CNBC Television - 1 month ago

Hydrafacial to go public in $1.1B SPAC deal led by Brent Saunders

Vesper Healthcare chairman Brent Saunders and Clint Carnell, CEO of Hydrafacial, join "Squawk on the Street" to discuss the deal to take Hydrafacial public via SPAC.

PRNewsWire - 2 months ago

MIAMI BEACH, Fla., Nov. 19, 2020 /PRNewswire/ -- Vesper Healthcare Acquisition Corp. (NASDAQ: VSPRU) (the "Company") announced that, commencing November 20, 2020, holders of the units sold in ...

Bloomberg Markets and Finance - 3 months ago

Vesper Healthcare CEO: Didn't Intent to Do SPAC

Oct.05 -- Vesper Heathcare Chief Executive Officer Brent Saunders discusses the outlook for an effective Covid-19 vaccine, and his intentions for his new blank-check firm. He speaks on "Bloomb...

PRNewsWire - 3 months ago

MIAMI BEACH, Fla., Oct. 2, 2020 /PRNewswire/ -- Vesper Healthcare Acquisition Corp. (NASDAQ:VSPRU) today announced the completion of its initial public offering of 46 million units at a price ...

CNBC Television - 3 months ago

Vesper Healthcare CEO discusses its decision to go public via SPAC

Vesper Healthcare Acquisition Corp. made its market debut on Sept. 30., pricing its initial public offering of 40 million units at $10.00 per unit. Former Allergan CEO Brent Saunders joins 'Cl...

PRNewsWire - 3 months ago

Brent Saunders, former Chairman and CEO of Allergan, is co-founder, CEO, President and Chairman of Vesper Healthcare

About VSPR

Vesper Healthcare Acquisition is a newly incorporated blank check company incorporated in July 2020 as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While we may pursue an acquisition opportunity in any industry or sector, we intend to focus on the pharmaceuticals and healthcare sectors with an emphasis on companies in the medical aesthetics, eye care, longevity and wellness categories. Ou... [Read more...]

Shell Companies
IPO Date
Sep 30, 2020
Brenton L. Saunders J.D.
United States
Stock Exchange
Ticker Symbol
Full Company Profile